AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 73 filers reported holding AKCEA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 5.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $294,000 | -75.8% | 16,219 | -80.9% | 0.00% | -100.0% |
| Q1 2020 | $1,214,000 | -13.3% | 84,871 | +2.7% | 0.00% | +50.0% |
| Q4 2019 | $1,400,000 | +321.7% | 82,646 | +484.4% | 0.00% | – |
| Q2 2019 | $332,000 | -78.1% | 14,142 | -77.9% | 0.00% | -100.0% |
| Q2 2018 | $1,517,000 | +389.4% | 63,998 | +428.7% | 0.00% | – |
| Q1 2018 | $310,000 | – | 12,104 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 3,162,643 | $53,575,000 | 0.85% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,723 | $536,000 | 0.19% |
| Amia Capital LLP | 28,217 | $478,000 | 0.14% |
| Motley Fool Asset Management LLC | 60,489 | $1,025,000 | 0.11% |
| Virtus ETF Advisers LLC | 33,059 | $560,000 | 0.09% |
| ALTRINSIC GLOBAL ADVISORS LLC | 70,286 | $1,191,000 | 0.05% |
| A.R.T. Advisors, LLC | 53,560 | $907,000 | 0.04% |
| TUDOR INVESTMENT CORP ET AL | 46,433 | $787,000 | 0.04% |
| Caption Management, LLC | 54,000 | $915,000 | 0.03% |
| Caption Management, LLC | 54,000 | $915,000 | 0.03% |